Corcept Therapeutics | CORT - Net Income



Corcept Therapeutics reported $35.15M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Acadia Pharmaceuticals USD 26.67M 7.68M Jun/2025
Alaunos Therapeutics USD -742000 385K Dec/2024
ANI Pharmaceuticals USD 8.14M 7.54M Jun/2025
Ardelyx USD -19080000 23.72M Jun/2025
Aurora Cannabis CAD -15210000 46.88M Jun/2025
BioMarin Pharmaceutical USD 240.53M 54.85M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Canopy Growth CAD -41530000 80.37M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Novartis USD 4.04B 1.22B Jun/2025
Pacira USD -4847000 9.66M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Supernus Pharmaceuticals USD 22.5M 34.33M Jun/2025
TG Therapeutics USD 28.19M 23.13M Jun/2025